BMO Capital lowered the firm’s price target on Equifax (EFX) to $195 from $234 and keeps a Market Perform rating on the shares. The company reported solid Q4 with large focus on FICO Mortgage pass-through revenues/margins and its proprietary data assets, though the stock has recently suffered given the pullback in origination volumes most visible in Mortgage, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EFX:
- Equifax price target lowered to $230 from $270 at UBS
- Equifax price target lowered to $250 from $289 at Baird
- Equifax: Resilient Data Moat and FICO-Driven Upside Undervalued, Supporting Buy Rating
- Equifax: Strong Operating Momentum and Capital Returns Underscore Attractive Buy-Rated Valuation Despite Regulatory Uncertainty
- Equifax price target lowered to $215 from $240 at Barclays